KDNY
$13.91
Chinook Therapeutics
$.31
2.28%
KDNY
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus:  ($0.57)
Revenue:  $0.00 Mil
Wednesday
Jul 7
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when KDNY reports earnings?
Beat
Meet
Miss

Where is KDNY's stock price going from here?
Up
Flat
Down
Stock chart of KDNY
Analysts
Summary of analysts' recommendations for KDNY
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Chinook Therapeutics, Inc. is a clinical-stage biotechnology company. It focuses on developing precision medicines for kidney diseases. Chinook Therapeutics, Inc., formerly known as Aduro Biotech Inc., is based in BERKELEY, Calif.